Literature DB >> 17112682

A hypothesis regarding complement activation and amniotic fluid embolism.

Michael D Benson1.   

Abstract

Amniotic fluid embolism, a rare, sudden and often fatal illness of pregnancy may not be a true embolic event resulting from the physical obstruction of the pulmonary vasculature. The high degree of variability in symptoms, the lack of characteristic findings on radiological exam, the absence of a dose-response effect on symptoms, and the occasional occurrence of coagulopathies are not entirely consistent with a physical block to the circulation as the main mechanism of disease. Alternatively, it might be the result of complement activation initiated by fetal antigen leaking into the maternal circulation. This rare immune response may be initiated by a rare pathological antigen, or by common antigens presented uncommonly--in amount, timing, or frequency of entry into the maternal circulation. Some very early evidence in AFE patients supports this hypothesis but is not conclusive. Complement levels remain well within the normal range during uncomplicated parturition. A prior theory that AFE might be a result of maternal anaphylaxis to fetal antigen has much less evidence to support it. The disseminated intravascular coagulation often seen in this and other serious obstetrical illnesses may be a secondary result of complement activation rather than the direct introduction of pro-coagulants into the maternal circulation although the link between the complement and coagulation pathways, if any, remains poorly defined. Through currently available laboratory testing, both the complement hypothesis and the anaphylaxis mechanism are able to be assessed. Direct measurement of serum complement as well as serum tryptase and urinary histamine are readily obtained tests in community hospitals as well as tertiary care hospitals. If the hypothesis proves true, this investigation may be of profound importance to understanding immune tolerance. Rather, than asking why one pregnant woman in 20,000 develops a violent immune reaction to the fetus, a better question is why do not all pregnant women reject the fetus which is a large collection of foreign antigens?

Entities:  

Mesh:

Year:  2006        PMID: 17112682     DOI: 10.1016/j.mehy.2006.09.052

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  13 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism.

Authors:  Vittorio Fineschi; Irene Riezzo; Santina Cantatore; Cristoforo Pomara; Emanuela Turillazzi; Margherita Neri
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

3.  Recurrent Cardiac Arrests Due to Amniotic Fluid Embolism.

Authors:  Munsef Barakat; Ans Alamami; Ali Ait Hssain
Journal:  Cureus       Date:  2022-02-21

Review 4.  Amniotic fluid embolism: an evidence-based review.

Authors:  Agustín Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2009-11       Impact factor: 8.661

Review 5.  Amniotic fluid embolism: an interdisciplinary challenge: epidemiology, diagnosis and treatment.

Authors:  Werner H Rath; Stefan Hoferr; Inga Sinicina
Journal:  Dtsch Arztebl Int       Date:  2014-02-21       Impact factor: 5.594

Review 6.  Amniotic fluid embolism: the known and not known.

Authors:  Michael D Benson
Journal:  Obstet Med       Date:  2013-11-29

Review 7.  Current concepts of immunology and diagnosis in amniotic fluid embolism.

Authors:  Michael D Benson
Journal:  Clin Dev Immunol       Date:  2011-09-29

Review 8.  Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.

Authors:  Francesco Paolo Busardò; Paola Frati; Simona Zaami; Vittorio Fineschi
Journal:  Int J Mol Sci       Date:  2015-03-23       Impact factor: 5.923

Review 9.  Maternal death analysis based on data from the nationwide registration system in Japan (2010-2018).

Authors:  Tomoko Wakasa; Hatsue Ishibashi-Ueda; Makoto Takeuchi
Journal:  Pathol Int       Date:  2021-02-09       Impact factor: 2.534

10.  The entry of fetal and amniotic fluid components into the uterine vessel circulation leads to sterile inflammatory processes during parturition.

Authors:  Hiroshi Kobayashi
Journal:  Front Immunol       Date:  2012-10-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.